Rchr
J-GLOBAL ID:201101094225624527
Update date: Sep. 04, 2023
Shimizu Tetsuo
シミズ テツオ | Shimizu Tetsuo
Affiliation and department:
Job title:
Associate professor
Research field (1):
Respiratory medicine
Research theme for competitive and other funds (1):
Papers (72):
-
Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane. Oncol Lett. 2021
-
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy. Int J Clin Oncol. 2021
-
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors. Jpn J Clin Oncol. 2021
-
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2021
-
Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser-assisted microdissection: A case report. Thorac Cancer. 2021
more...
MISC (1):
-
權 寧博, 清水哲男, 橋本 修. 【今わが国のACO(asthma COPD overlap)を再考する】ACOをどう診断するか.2018. 呼吸器内科. 2018. 34. 5. 431-435
Books (2):
-
呼吸器疾患文献レビュー
学研メディカル秀潤社 2014
-
慢性閉塞性肺疾患(COPD)のマネジメント
医薬ジャーナル社 2013
Lectures and oral presentations (171):
-
当院で経験したびまん性肺胞出血10例の臨床的検討.
(第42回日本呼吸器内視鏡学会学術集会 2019)
-
ROS1融合遺伝子解析を例とした呼吸器細胞診検体のRNA解析への活用(ワークショップ:肺癌治療と細胞診の活用).
(第60回日本臨床細胞学会春期大会 2019)
-
当院で経験した結核性胸膜炎患者の検討.
(第59回日本呼吸器学会学術講演会 2019)
-
80歳以上の高齢者非小細胞肺癌における免疫チェックポイント阻害剤投与症例の臨床的検討.
(第59回日本呼吸器学会学術講演会 2019)
-
小細胞肺癌株におけるSulforaphane誘導性ferroptosisの作用機序と多剤耐性株への効果の検討
(第59回日本呼吸器学会学術講演会 2019)
more...
Professional career (1):
Return to Previous Page